Roivant Sciences (ROIV) Return on Sales [ROS] (2020 - 2026)
Roivant Sciences' Return on Sales [ROS] came in at -25380.93% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 12250.88 percentage points from -13130.05% a year earlier and down 41858.71 percentage points from the prior quarter.
Roivant Sciences (ROIV) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Roivant Sciences reported Return on Sales [ROS] of -7914.75%, down 2810.02 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at -6235.69%, down 2782.37 percentage points from FY2025.
- Return on Sales [ROS] carries a five-year change of -1735.17 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Sales [ROS] was -3453.32% in FY2025 (-17200.25 pp), 13746.93% in FY2024 (+16622.80 pp), -2875.87% in FY2023 (-431.06 pp) and -2444.82% in FY2022 (+2055.70 pp).
- The fiscal Q1 2027 figure represents the lowest quarterly Return on Sales [ROS] in data going back to fiscal Q1 2021.
- Year-over-year, Return on Sales [ROS] increased in 1 of the last eight quarters, with an average year-over-year change of -8609.36 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in fiscal Q3 2024 (a gain of 35165.76 percentage points), and the weakest in fiscal Q3 2025 (a drop of 35991.15 percentage points).
- Business Quant data shows ROIV's Return on Sales [ROS] at 16477.78% (Q4 2026), -16966.13% (Q3 2026) and -19492.87% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Roivant Sciences | 25.81 Bn | 26.50 Bn | 1.16 Mn | -25,380.93% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25,380.93% |
| Mar 31, 2026 | 16,477.78% |
| Dec 31, 2025 | -16,966.13% |
| Sep 30, 2025 | -19,492.87% |
| Jun 30, 2025 | -13,130.05% |
| Mar 31, 2025 | -3,764.40% |
| Dec 31, 2024 | -3,042.59% |
| Sep 30, 2024 | -7,636.04% |
| Jun 30, 2024 | -1,279.54% |
| Mar 31, 2024 | -2,293.06% |
| Dec 31, 2023 | 32,948.56% |
| Sep 30, 2023 | -5,863.24% |
| Jun 30, 2023 | -1,278.27% |
| Mar 31, 2023 | -2,875.87% |
| Dec 31, 2022 | -2,217.20% |
| Sep 30, 2022 | -2,240.21% |
| Jun 30, 2022 | -6,536.44% |
| Mar 31, 2022 | -2,892.80% |
| Dec 31, 2021 | -1,010.73% |
| Sep 30, 2021 | -4,893.32% |
Roivant Sciences Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();